However, the failure to see an effect of the loss of MSH2 at FRDA alleles suggests that there is more than one mechanism involved in the maintenance of DNA methylation upstream of the expanded repeats, with the MSH2-independent process being responsible for the gene silencing in FXS and FRDA that causes disease pathology. Here, MSH2 is linked to fragile X syndrome.